These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 22891448)

  • 1. [Pharmacogenetics, a valuable aid to therapeutic monitoring of immunosuppressives and antiretrovirals].
    Haufroid V
    Bull Mem Acad R Med Belg; 2011; 166(5-6):191-8; discussion 199-201. PubMed ID: 22891448
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Update on the pharmacokinetic aspects of antiretroviral agents: implications in therapeutic drug monitoring.
    Slish JC; Catanzaro LM; Ma Q; Okusanya OO; Demeter L; Albrecht M; Morse GD
    Curr Pharm Des; 2006; 12(9):1129-45. PubMed ID: 16515491
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetic considerations related to therapeutic drug monitoring of tacrolimus in kidney transplant patients.
    Andrews LM; Li Y; De Winter BCM; Shi YY; Baan CC; Van Gelder T; Hesselink DA
    Expert Opin Drug Metab Toxicol; 2017 Dec; 13(12):1225-1236. PubMed ID: 29084469
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current progress in pharmacogenetics and individualized immunosuppressive drug dosing in organ transplantation.
    Ware N; MacPhee IA
    Curr Opin Mol Ther; 2010 Jun; 12(3):270-83. PubMed ID: 20521216
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of therapeutic drug monitoring in the management of patients with human immunodeficiency virus infection.
    Pretorius E; Klinker H; Rosenkranz B
    Ther Drug Monit; 2011 Jun; 33(3):265-74. PubMed ID: 21566505
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A computer-based system to aid in the interpretation of plasma concentrations of antiretrovirals for therapeutic drug monitoring.
    Goicoechea M; Vidal A; Capparelli E; Rigby A; Kemper C; Diamond C; Witt MD; Haubrich R;
    Antivir Ther; 2007; 12(1):55-62. PubMed ID: 17503748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Therapeutic drug monitoring: clinical practice].
    Widmer N; Werner D; Grouzmann E; Eap CB; Marchetti O; Fayet A; Csajka C; Decosterd LA; Buclin T
    Rev Med Suisse; 2008 Jul; 4(165):1649-50, 1652-60. PubMed ID: 18767291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacogenetics: the therapeutic drug monitoring of the future?
    Ensom MH; Chang TK; Patel P
    Clin Pharmacokinet; 2001; 40(11):783-802. PubMed ID: 11735602
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetic optimization of antiretroviral therapy in children and adolescents.
    Neely MN; Rakhmanina NY
    Clin Pharmacokinet; 2011 Mar; 50(3):143-89. PubMed ID: 21294595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Principles of therapeutic drug monitoring].
    Widmer N; Csajka C; Werner D; Grouzmann E; Decosterd LA; Eap CB; Biollaz J; Buclin T
    Rev Med Suisse; 2008 Jul; 4(165):1644-8. PubMed ID: 18767290
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacogenetics of immunosuppressive drugs: prospect of individual therapy for transplant patients.
    Ekbal NJ; Holt DW; Macphee IA
    Pharmacogenomics; 2008 May; 9(5):585-96. PubMed ID: 18466104
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Precision medicine for HIV: where are we?
    Cusato J; Allegra S; Nicolò A; Calcagno A; D'Avolio A
    Pharmacogenomics; 2018 Jan; 19(2):145-165. PubMed ID: 29202676
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Precision HIV care: responding to old questions and meeting new challenges.
    Hulgan T; Dash C; Haas DW; Phillips EJ
    Pharmacogenomics; 2018 Nov; 19(17):1299-1302. PubMed ID: 30325267
    [No Abstract]   [Full Text] [Related]  

  • 14. Practicability of pharmacogenetics in transplantation medicine.
    van Gelder T; van Schaik RH; Hesselink DA
    Clin Pharmacol Ther; 2014 Mar; 95(3):262-4. PubMed ID: 23995265
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genes and beans: pharmacogenomics of renal transplant.
    Murray B; Hawes E; Lee RA; Watson R; Roederer MW
    Pharmacogenomics; 2013 May; 14(7):783-98. PubMed ID: 23651025
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Opportunities to optimize tacrolimus therapy in solid organ transplantation: report of the European consensus conference.
    Wallemacq P; Armstrong VW; Brunet M; Haufroid V; Holt DW; Johnston A; Kuypers D; Le Meur Y; Marquet P; Oellerich M; Thervet E; Toenshoff B; Undre N; Weber LT; Westley IS; Mourad M
    Ther Drug Monit; 2009 Apr; 31(2):139-52. PubMed ID: 19177031
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Developmental pharmacogenetics of immunosuppressants in pediatric organ transplantation.
    Zhao W; Fakhoury M; Jacqz-Aigrain E
    Ther Drug Monit; 2010 Dec; 32(6):688-99. PubMed ID: 21068645
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic drug monitoring of cyclosporine.
    Midtvedt K
    Transplant Proc; 2004 Mar; 36(2 Suppl):430S-433S. PubMed ID: 15041380
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetic principles of immunosuppressive drugs.
    Budde K; Glander P
    Ann Transplant; 2008; 13(3):5-10. PubMed ID: 18806727
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic drug monitoring: pharmacologic considerations for antiretroviral drugs.
    Kiser JJ; Anderson PL; Gerber JG
    Curr HIV/AIDS Rep; 2005 Jun; 2(2):61-7. PubMed ID: 16091250
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.